These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23538073)

  • 1. Omega-3 fatty acids in psychiatry.
    Mischoulon D; Freeman MP
    Psychiatr Clin North Am; 2013 Mar; 36(1):15-23. PubMed ID: 23538073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
    McKenney JM; Sica D
    Pharmacotherapy; 2007 May; 27(5):715-28. PubMed ID: 17461707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omacor (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia.
    Rupp H
    Adv Ther; 2009 Jul; 26(7):675-90. PubMed ID: 19629408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids.
    Bays H
    Am J Cardiol; 2006 Aug; 98(4A):71i-76i. PubMed ID: 16919519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 polyunsaturated fatty acids (Omacor) for hypertriglyceridemia.
    Med Lett Drugs Ther; 2005 Nov; 47(1221):91. PubMed ID: 16267495
    [No Abstract]   [Full Text] [Related]  

  • 6. The emerging role of omega-3 fatty acids in psychiatry.
    McNamara RK
    Prostaglandins Leukot Essent Fatty Acids; 2006; 75(4-5):223-5. PubMed ID: 16930969
    [No Abstract]   [Full Text] [Related]  

  • 7. [Additional omega-3-fatty acids. Infarct mortality gets reduced].
    MMW Fortschr Med; 2003 Mar; 145(10):58. PubMed ID: 12688033
    [No Abstract]   [Full Text] [Related]  

  • 8. Triglycerides & omega-3s. Prescription omega-3 fatty acids are now among the hypertriglyceridemia therapies.
    Park NH
    Adv NPs PAs; 2010 Dec; 1(4):36-40. PubMed ID: 21319452
    [No Abstract]   [Full Text] [Related]  

  • 9. The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans.
    Mori TA; Woodman RJ
    Curr Opin Clin Nutr Metab Care; 2006 Mar; 9(2):95-104. PubMed ID: 16477172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical application of omega 3 polyunsaturated fatty acids in psychiatry].
    Nakagome K; Yamada T; Matsumura H; Sakaki N; Sunao M
    Seishin Shinkeigaku Zasshi; 2009; 111(12):1512-9. PubMed ID: 20344878
    [No Abstract]   [Full Text] [Related]  

  • 11. Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?
    Ross BM; Seguin J; Sieswerda LE
    Lipids Health Dis; 2007 Sep; 6():21. PubMed ID: 17877810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omega-3 fatty acids and depression: from cellular mechanisms to clinical care.
    Freeman MP; Rapaport MH
    J Clin Psychiatry; 2011 Feb; 72(2):258-9. PubMed ID: 21382308
    [No Abstract]   [Full Text] [Related]  

  • 13. 'Side effects of eicosapentaenoic acid and docosahexaenoic acid (maxepa)'.
    Mehta VR
    J Assoc Physicians India; 1992 Jul; 40(7):486. PubMed ID: 1484043
    [No Abstract]   [Full Text] [Related]  

  • 14. [Long-chain omega-3 fatty acids: highly concentrated only as ethyl ester].
    MMW Fortschr Med; 2005 Oct; 147(43):61. PubMed ID: 16302427
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mood disorders and omega 3 polyunsaturated fatty acids].
    Ozawa H
    Seishin Shinkeigaku Zasshi; 2009; 111(12):1507-11. PubMed ID: 20344877
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of glucosamine sulfate with or without omega-3 fatty acids in patients with osteoarthritis.
    Gruenwald J; Petzold E; Busch R; Petzold HP; Graubaum HJ
    Adv Ther; 2009 Sep; 26(9):858-71. PubMed ID: 19756416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
    Davidson MH; Stein EA; Bays HE; Maki KC; Doyle RT; Shalwitz RA; Ballantyne CM; Ginsberg HN;
    Clin Ther; 2007 Jul; 29(7):1354-67. PubMed ID: 17825687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of omega-3 fatty acids in children and adults with IgA nephropathy is dosage- and size-dependent.
    Hogg RJ; Fitzgibbons L; Atkins C; Nardelli N; Bay RC;
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1167-72. PubMed ID: 17699343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia.
    Skulas-Ray AC; West SG; Davidson MH; Kris-Etherton PM
    Expert Opin Pharmacother; 2008 May; 9(7):1237-48. PubMed ID: 18422480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Obesity on Breast Density Reduction by Omega-3 Fatty Acids: Evidence from a Randomized Clinical Trial.
    Sandhu N; Schetter SE; Liao J; Hartman TJ; Richie JP; McGinley J; Thompson HJ; Prokopczyk B; DuBrock C; Signori C; Hamilton C; Calcagnotto A; Trushin N; Aliaga C; Demers LM; El-Bayoumy K; Manni A
    Cancer Prev Res (Phila); 2016 Apr; 9(4):275-82. PubMed ID: 26714774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.